Viewing Study NCT01497392


Ignite Creation Date: 2025-12-24 @ 3:57 PM
Ignite Modification Date: 2026-06-15 @ 6:14 PM
Study NCT ID: NCT01497392
Status: COMPLETED
Last Update Posted: 2022-07-22
First Post: 2011-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers
Sponsor: Roswell Park Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of the Pancreas View
None Stage III Pancreatic Cancer View
None Stage IV Pancreatic Cancer View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords: